KraneShares MSCI All China Health Care ETF News

Top Performing Unleveraged ETFs Last Week These were last week's top-performing ETFs. We've excluded funds that use leverage or make inverse bets on their underlying assets.

The latest batch of official PMI data gave a nice boost to Chinese equities and also commodities. While China's supply-side stimulus allows to “mobilize” the official sector fairly quickly, it doe

The health care industry in China is expected to expand rapidly in the coming years with a rapidly aging population, growing infrastructure, and China's growing role in the global health care system t

The most recent macroeconomic figures show that the Chinese slowdown is much more severe than expected and not only attributable to the Covid-19 lockdowns. It is easy to use the Covid-19 lockdowns as

The deficit spending that supported the economy in 2020 is showing up in hot inflation numbers in 2021. While I think the inflation numbers will get better in 2022, I do not believe they will get back

China has not solved the unravelling crisis in its development/construction sector. The nation has moved through all the ‘natural' stages an economy goes through when implementing the free market ca

The newest ETF is a fund-of-funds composed of existing China ETFs.

The bankruptcy of the Chinese real estate company Evergrande is much more than a “Chinese Lehman”. The implications of an Evergrande collapse are far greater than what investment banks tell us.

Chinese government has generally had some idea of how much risk Evergrande and other highly leveraged real estate companies pose since last year. Equity holders will most likely be wiped out, with hol

The impact of the policy remedy to China's property market excesses is spreading across global markets. But they would bounce hard on any evidence of a mitigation plan from Beijing.

In some form or fashion, hundreds of exchange traded funds offer exposure to Chinese equities. As the world's second-largest country has evolved, so have the related ETF offerings.

Asian markets ended last week up, buoyed in part by a rally in healthcare firms, according to Reuters. The blue-chip CSI300 Index, which tracks the top 300 stocks traded on the Shenzhen Stock Exchange

ETF investors looking for growth and innovation in China, can turn to the KraneShares Krane China Innovation Strategy. The strategy consists of a model portfolio that seeks to provide investors exposu

Wall Street was downbeat last week on inflationary concerns and some downbeat economic data points.

Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike with three big U.S. indexes remaining in the red.